Access to oxytocin and misoprostol for management of postpartum haemorrhage in Kenya, Uganda and Zambia: a cross-sectional assessment of availability, prices and affordability

Author:

Kibira DenisORCID,Ooms Gaby Isabelle,van den Ham Hendrika A.,Namugambe Juliet Sanyu,Reed Tim,Leufkens Hubert GM,Mantel-Teeuwisse AukjeORCID

Abstract

ObjectiveTo assess access (availability and affordability) to oxytocin and misoprostol at health facilities in Kenya, Uganda and Zambia to improve prevention and management of postpartum haemorrhage (PPH).DesignThe assessment was undertaken using data from Health Action International (HAI) research on sexual and reproductive health commodities based on a cross-sectional design adapted from the standardised WHO/HAI methodology.SettingData were collected from 376 health facilities in in Kenya, Uganda and Zambia in July and August 2017.Outcome measuresAvailability was calculated as mean percentage of sampled medicine outlets where medicine was found on the day of data collection. Medicine prices were compared with international reference prices (IRP) and expressed as median price ratios. Affordability was calculated using number of days required to pay for a standard treatment based on the daily income of the lowest paid government worker.ResultsAvailability of either oxytocin or misoprostol at health facilities was high; 81% in Kenya, 82% in Uganda and 76% in Zambia. Oxytocin was more available than misoprostol, and it was most available in the public sector in the three countries. Availability of misoprostol was highest in the public sector in Uganda (88%). Oxytocin and misoprostol were purchased by patients at prices above IRP, but both medicines cost less than a day’s wages and were therefore affordable. Availability of misoprostol was poor in rural settings where it would be more preferred due to lack of trained personnel and cold storage facilities required for oxytocin.ConclusionAvailability and affordability of either oxytocin or misoprostol at health facilities met the WHO benchmark of 80%. However, countries with limited resources should explore mechanisms to optimise management of PPH by improving access to misoprostol especially in rural areas.

Publisher

BMJ

Subject

General Medicine

Reference50 articles.

1. World Health Organization . Trends in maternal mortality: 2000 to 2017: estimates by who, UNICEF, UNFPA, world bank group and the United nations population division. Geneva: World Health Organization, 2019.

2. Global causes of maternal death: a WHO systematic analysis;Say;Lancet Glob Health,2014

3. PSI . Improving maternal health: preventing post-partum hemorrhage in Rural Zambia. Washington D.C: PSI, 2014.

4. Management of postpartum hemorrhage in a rural hospital in Kenya: a best practice implementation project;Kinuthia;JBI Database System Rev Implement Rep,2019

5. Incidence and risk factors for postpartum hemorrhage in Uganda;Ononge;Reprod Health,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3